Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Muggia

Showing results (161-170 of 424) with videos related to

Pageof 43
Sort By:
Molecular Cancer Therapeutics|May 7, 2009
XIII International Charles Heidelberger Symposium and 50 Years of Fluoropyrimidines in Cancer Therapy Held on september 6 to 8, 2007 at New York University Cancer Institute, Smilow Conference CenterFranco M Muggia, Godefridus J Peters, Joseph R Landolph
Cancer|April 1, 1977
Adjuvant chemotherapy in lung cancer: review and prospectsS S Legha, F M Muggia, S K Carter
Cancer Treatment Reviews|December 1, 1983
Pulmonary toxicity of antitumor agentsF M Muggia, A C Louie, B I Sikic
Advances in Pharmacology and Chemotherapy|January 1, 1978
Immune modulation and cancer controlS M Mikulski, M A Chirigos, F M Muggia
European Journal of Cancer & Clinical Oncology|February 1, 1984
Cardiotoxicity of anthracyclinesM D Green, J L Speyer, F M Muggia
Lancet (London, England)|January 10, 1976
Letter: Allergic reactions to cis platinumD D Von Hoff, M Slavik, F M Muggia
Cancer Treatment Reports|June 1, 1983
Kaposi's sarcoma: a new staging classificationR L Krigel, L J Laubenstein, F M Muggia
Cancer Treatment Reports|January 1, 1981
Future clinical investigations with anthracycline antibiotics in relation to daunorubicinF M Muggia, R H Blum, J C Wernz
Annals of Internal Medicine|August 1, 1976
5-Azacytidine. A new anticancer drug with effectiveness in acute myelogenous leukemiaD D Von Hoff, M Slavik, F M Muggia
New York State Journal of Medicine|May 1, 1981
Lung cancer. Chemotherapy as curative treatmentL M Howard, R H Blum, F M Muggia
Pageof 43

Showing results (161-170 of 424) with videos related to

Sort By:
Pageof 43
Molecular Cancer Therapeutics|May 7, 2009
XIII International Charles Heidelberger Symposium and 50 Years of Fluoropyrimidines in Cancer Therapy Held on september 6 to 8, 2007 at New York University Cancer Institute, Smilow Conference CenterFranco M Muggia, Godefridus J Peters, Joseph R Landolph
Cancer|April 1, 1977
Adjuvant chemotherapy in lung cancer: review and prospectsS S Legha, F M Muggia, S K Carter
Cancer Treatment Reviews|December 1, 1983
Pulmonary toxicity of antitumor agentsF M Muggia, A C Louie, B I Sikic
Advances in Pharmacology and Chemotherapy|January 1, 1978
Immune modulation and cancer controlS M Mikulski, M A Chirigos, F M Muggia
European Journal of Cancer & Clinical Oncology|February 1, 1984
Cardiotoxicity of anthracyclinesM D Green, J L Speyer, F M Muggia
Lancet (London, England)|January 10, 1976
Letter: Allergic reactions to cis platinumD D Von Hoff, M Slavik, F M Muggia
Cancer Treatment Reports|June 1, 1983
Kaposi's sarcoma: a new staging classificationR L Krigel, L J Laubenstein, F M Muggia
Cancer Treatment Reports|January 1, 1981
Future clinical investigations with anthracycline antibiotics in relation to daunorubicinF M Muggia, R H Blum, J C Wernz
Annals of Internal Medicine|August 1, 1976
5-Azacytidine. A new anticancer drug with effectiveness in acute myelogenous leukemiaD D Von Hoff, M Slavik, F M Muggia
New York State Journal of Medicine|May 1, 1981
Lung cancer. Chemotherapy as curative treatmentL M Howard, R H Blum, F M Muggia
Pageof 43